Position in CYTK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$557,994
+$270,363 QoQ
Shares Held
6,550
+50.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#301
of 480 holders
Holding Since
Sep 2020
17 quarters on record
Voting authority
Sole 4%
Shared 0%
None 96%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $167,363,866 across 124 Biotechnology names. CYTK ranks #39 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,464 | $22,736,762 | |
| 2 | RPRX |
Royalty Pharma plc
|
337,298 | $18,912,298 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
35,471 | $17,619,509 | |
| 4 | EXEL |
Exelixis, Inc.
|
303,042 | $16,488,515 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
34,607 | $10,938,926 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
125,946 | $9,857,793 | |
| 7 | CELC |
Celcuity Inc.
|
71,445 | $7,474,575 | |
| 8 | INCY |
Incyte Corp
|
50,301 | $5,702,121 |
All Filings in CYTK
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $557,994 | 6,550 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $287,631 | 4,364 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $295,397 | 4,649 | Shares | Sole | 2026-02-17 | |
| 2023-12-31 | $1,023,420 | 12,258 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $447,968 | 15,206 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $331,778 | 10,171 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $358,550 | 10,189 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $498,338 | 10,876 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $202,375 | 4,177 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $152,170 | 3,873 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $143,927 | 3,910 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $99,136 | 2,175 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $77,091 | 2,157 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $41,836 | 2,114 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $49,567 | 2,131 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,909 | 140 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $8,660 | 400 | Shares | Sole | 2020-11-17 | |
| No filing history on record for this holder in this stock. | ||||||